{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T21:20:57Z","timestamp":1758057657962,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.rce.2019.09.001","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T16:52:30Z","timestamp":1572713550000},"page":"24-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metformina e inhibidores del cotransportador sodio-glucosa en el tratamiento de la diabetes mellitus tipo 1: man\u00e9jese con cuidado"],"prefix":"10.1016","volume":"220","author":[{"given":"J.","family":"Ena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"G\u00f3mez-Huelgas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.rce.2019.09.001_bib0075","first-page":"S13","article-title":"Classification and diagnosis of diabetes: Standards of medical care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care."},{"key":"10.1016\/j.rce.2019.09.001_bib0080","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1210\/jcem.87.3.8324","article-title":"Insulin resistance, intra-abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus","volume":"87","author":"Greenfield","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rce.2019.09.001_bib0085","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db10-0328","article-title":"Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes","volume":"60","author":"Schauer","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.rce.2019.09.001_bib0090","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2018.03.099","article-title":"Type 1 and type 2 diabetes mellitus and incidence of seven cardiovascular diseases","volume":"262","author":"Larsson","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.rce.2019.09.001_bib0095","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1161\/CIRCULATIONAHA.118.037454","article-title":"Relative Prognostic importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus","volume":"139","author":"Rawshani","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.rce.2019.09.001_bib0100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/db18-0515","volume":"68","author":"Miller","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.rce.2019.09.001_bib0105","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet."},{"key":"10.1016\/j.rce.2019.09.001_bib0110","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1210\/jc.2017-00781","article-title":"Effect of metformin on vascular function in children with type 1 diabetes: A 12-month randomized controlled trial","volume":"102","author":"Anderson","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.rce.2019.09.001_bib0115","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(17)30194-8","article-title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): A double-blind, randomised, placebo-controlled trial","volume":"5","author":"Petrie","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"10.1016\/j.rce.2019.09.001_bib0120","first-page":"S103","article-title":"10. Cardiovascular disease and risk management: Standards of medical care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care."},{"key":"10.1016\/j.rce.2019.09.001_bib0125","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.rce.2019.06.010","article-title":"Eficacia y seguridad de la metformina de sodio y de los inhibidores del co-trasportador sodio-glucosa en adultos con diabetes tipo 1: una revisi\u00f3n sistem\u00e1tica y metaan\u00e1lisis en red","volume":"220","author":"Zhang","year":"2020","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2019.09.001_bib0130","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.2337\/dc17-0403","article-title":"Use of Adjuvant Pharmacotherapy in Type 1 Diabetes: International Comparison of 49,996 Individuals in the Prospective Diabetes Follow-up and T1D Exchange Registries","volume":"40","author":"Lyons","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rce.2019.09.001_bib0135","unstructured":"Astellas Pharma. Approval of Suglat\u00ae\u00a0Tablets, Selective SGLT2 Inhibitor, for Additional Indication of type 1 diabetes mellitus and Additional dosage and administration in Japan. [consultado 20 Ago 2019] Disponible en: https:\/\/www.astellas.com\/en\/news\/14481"},{"key":"10.1016\/j.rce.2019.09.001_bib0140","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/dc18-2316","article-title":"International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors","volume":"42","author":"Danne","year":"2019","journal-title":"Diabetes Care"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256519302279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256519302279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:39:16Z","timestamp":1757972356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256519302279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0014256519302279"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2019.09.001","relation":{},"ISSN":["0014-2565"],"issn-type":[{"type":"print","value":"0014-2565"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformina e inhibidores del cotransportador sodio-glucosa en el tratamiento de la diabetes mellitus tipo 1: man\u00e9jese con cuidado","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2019.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2019.06.010","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights reserved.","name":"copyright","label":"Copyright"}]}}